Oxford BioMedica plc (LON:OXB)’s share price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $651.66 and traded as high as $695.00. Oxford BioMedica shares last traded at $675.00, with a volume of 36,833 shares changing hands.
A number of research firms have weighed in on OXB. Liberum Capital increased their target price on Oxford BioMedica from GBX 810 ($10.66) to GBX 860 ($11.31) and gave the stock a “buy” rating in a research note on Monday, January 13th. Peel Hunt reiterated a “buy” rating on shares of Oxford BioMedica in a research report on Friday, January 10th.
The company’s 50 day moving average is GBX 657.02 and its 200 day moving average is GBX 618.07. The company has a market cap of $502.66 million and a PE ratio of -56.38. The company has a current ratio of 2.21, a quick ratio of 1.80 and a debt-to-equity ratio of 10.55.
Oxford BioMedica Company Profile (LON:OXB)
Oxford BioMedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of lentiviral vector and cell therapy products for the treatment of various cancers, Parkinson's, central nervous system disorders, and ocular conditions in Europe and internationally. The company operates through Platform and Product segments.
See Also: What causes a stock to be most active?
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.